Cargando…

Long-Term Treatment with Citicoline Prevents Cognitive Decline and Predicts a Better Quality of Life after a First Ischemic Stroke

Stroke, as the leading cause of physical disability and cognitive impairment, has a very significant impact on patients’ quality of life (QoL). The objective of this study is to know the effect of citicoline treatment in Qol and cognitive performance in the long-term in patients with a first ischemi...

Descripción completa

Detalles Bibliográficos
Autores principales: Alvarez-Sabín, Jose, Santamarina, Estevo, Maisterra, Olga, Jacas, Carlos, Molina, Carlos, Quintana, Manuel
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4813246/
https://www.ncbi.nlm.nih.gov/pubmed/26999113
http://dx.doi.org/10.3390/ijms17030390
_version_ 1782424273754783744
author Alvarez-Sabín, Jose
Santamarina, Estevo
Maisterra, Olga
Jacas, Carlos
Molina, Carlos
Quintana, Manuel
author_facet Alvarez-Sabín, Jose
Santamarina, Estevo
Maisterra, Olga
Jacas, Carlos
Molina, Carlos
Quintana, Manuel
author_sort Alvarez-Sabín, Jose
collection PubMed
description Stroke, as the leading cause of physical disability and cognitive impairment, has a very significant impact on patients’ quality of life (QoL). The objective of this study is to know the effect of citicoline treatment in Qol and cognitive performance in the long-term in patients with a first ischemic stroke. This is an open-label, randomized, parallel study of citicoline vs. usual treatment. All subjects were selected 6 weeks after suffering a first ischemic stroke and randomized into parallel arms. Neuropsychological evaluation was performed at 1 month, 6 months, 1 year and 2 years after stroke, and QoL was measured using the EuroQoL-5D questionnaire at 2 years. 163 patients were followed during 2 years. The mean age was 67.5 years-old, and 50.9% were women. Age and absence of citicoline treatment were independent predictors of both utility and poor quality of life. Patients with cognitive impairment had a poorer QoL at 2 years (0.55 vs. 0.66 in utility, p = 0.015). Citicoline treatment improved significantly cognitive status during follow-up (p = 0.005). In conclusion, treatment with long-term citicoline is associated with a better QoL and improves cognitive status 2 years after a first ischemic stroke.
format Online
Article
Text
id pubmed-4813246
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-48132462016-04-06 Long-Term Treatment with Citicoline Prevents Cognitive Decline and Predicts a Better Quality of Life after a First Ischemic Stroke Alvarez-Sabín, Jose Santamarina, Estevo Maisterra, Olga Jacas, Carlos Molina, Carlos Quintana, Manuel Int J Mol Sci Article Stroke, as the leading cause of physical disability and cognitive impairment, has a very significant impact on patients’ quality of life (QoL). The objective of this study is to know the effect of citicoline treatment in Qol and cognitive performance in the long-term in patients with a first ischemic stroke. This is an open-label, randomized, parallel study of citicoline vs. usual treatment. All subjects were selected 6 weeks after suffering a first ischemic stroke and randomized into parallel arms. Neuropsychological evaluation was performed at 1 month, 6 months, 1 year and 2 years after stroke, and QoL was measured using the EuroQoL-5D questionnaire at 2 years. 163 patients were followed during 2 years. The mean age was 67.5 years-old, and 50.9% were women. Age and absence of citicoline treatment were independent predictors of both utility and poor quality of life. Patients with cognitive impairment had a poorer QoL at 2 years (0.55 vs. 0.66 in utility, p = 0.015). Citicoline treatment improved significantly cognitive status during follow-up (p = 0.005). In conclusion, treatment with long-term citicoline is associated with a better QoL and improves cognitive status 2 years after a first ischemic stroke. MDPI 2016-03-16 /pmc/articles/PMC4813246/ /pubmed/26999113 http://dx.doi.org/10.3390/ijms17030390 Text en © 2016 by the authors; licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons by Attribution (CC-BY) license (http://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Alvarez-Sabín, Jose
Santamarina, Estevo
Maisterra, Olga
Jacas, Carlos
Molina, Carlos
Quintana, Manuel
Long-Term Treatment with Citicoline Prevents Cognitive Decline and Predicts a Better Quality of Life after a First Ischemic Stroke
title Long-Term Treatment with Citicoline Prevents Cognitive Decline and Predicts a Better Quality of Life after a First Ischemic Stroke
title_full Long-Term Treatment with Citicoline Prevents Cognitive Decline and Predicts a Better Quality of Life after a First Ischemic Stroke
title_fullStr Long-Term Treatment with Citicoline Prevents Cognitive Decline and Predicts a Better Quality of Life after a First Ischemic Stroke
title_full_unstemmed Long-Term Treatment with Citicoline Prevents Cognitive Decline and Predicts a Better Quality of Life after a First Ischemic Stroke
title_short Long-Term Treatment with Citicoline Prevents Cognitive Decline and Predicts a Better Quality of Life after a First Ischemic Stroke
title_sort long-term treatment with citicoline prevents cognitive decline and predicts a better quality of life after a first ischemic stroke
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4813246/
https://www.ncbi.nlm.nih.gov/pubmed/26999113
http://dx.doi.org/10.3390/ijms17030390
work_keys_str_mv AT alvarezsabinjose longtermtreatmentwithciticolinepreventscognitivedeclineandpredictsabetterqualityoflifeafterafirstischemicstroke
AT santamarinaestevo longtermtreatmentwithciticolinepreventscognitivedeclineandpredictsabetterqualityoflifeafterafirstischemicstroke
AT maisterraolga longtermtreatmentwithciticolinepreventscognitivedeclineandpredictsabetterqualityoflifeafterafirstischemicstroke
AT jacascarlos longtermtreatmentwithciticolinepreventscognitivedeclineandpredictsabetterqualityoflifeafterafirstischemicstroke
AT molinacarlos longtermtreatmentwithciticolinepreventscognitivedeclineandpredictsabetterqualityoflifeafterafirstischemicstroke
AT quintanamanuel longtermtreatmentwithciticolinepreventscognitivedeclineandpredictsabetterqualityoflifeafterafirstischemicstroke